Trial Profile
To compare the effects of Febuxostat treatment in patients with chronic gout previously managed with allopurinol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2017
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2017 New trial record
- 08 Nov 2017 Results comparing effects of febuxostat treatment in chronic gout patients previously treated with allopurinol, presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.